Episode 69: Hans Sollinger, MD, PhD, Founder & Interim CSO of Endsulin

episode

TheSugarScience Podcast- curating the scientific conversation in type 1 diabetes not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Danny Parkins sounds off on discourse surrounding Caleb Williams' injury (Hour 2) 40 min · 24 Sep 2026 · Rahimi & Grote Show

Cubs squander chance to clinch playoff berth in losing to Marlins, 3-2 (Hour 1) 42 min · 24 Sep 2026 · Rahimi & Grote Show

Danny Parkins sounds off on discourse surrounding Caleb Williams' injury 19 min · 24 Sep 2026 · Rahimi & Grote Show

The AWP: HR Without the Drama: Handbooks, Hard Conversations & Documentation 57 min · 24 Sep 2026 · EyeCode Media

710: That New Mouse Pad Feeling 2h 13m · 24 Sep 2026 · Accidental Tech Podcast

Steven Bartlett REVEALS the Secret Behind the World’s Fastest Growing Podcast | PBD Podcast #861 1h 27m · 24 Sep 2026 · PBD Podcast

Report any issue

Source

Recorded30 Mar 2021

Publisherfeed.podbean.com ↗

Handlerec:2095119

Show notes

In this episode, we speak to Dr. Hans Sollinger, MD, PhD, Founder & Interim CSO of Endsulin. Dr. Sollinger has been a leader in diabetes care for decades and has revolutionized the field twice. Endsulin is overcoming the limitations of today's taxing diabetes treatments with a patented gene construct and simple process that re-engineers part of the liver, allowing it to produce and regulate insulin on its own. Learn more about Endsulin here!

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in